LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
31 hedge funds and large institutions have $14M invested in Landos Biopharma, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$55K | |
| 2 | +$25.3K | |
| 3 | +$10K | |
| 4 |
Man Group
London,
United Kingdom
|
+$9K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$729 |
Top Sellers
| 1 | -$244K | |
| 2 | -$195K | |
| 3 | -$84.4K | |
| 4 |
Goldman Sachs
New York
|
-$20.4K |
| 5 |
Two Sigma Investments
New York
|
-$18.1K |